Jci_page_head_homepage_01 Jci_page_head_homepage_02
Denise M. Kirby, Renato Salemi, Canny Sugiana, Akira Ohtake, Lee Parry, Katrina M. Bell, Edwin P. Kirk, Avihu Boneh, Robert W. Taylor, Hans-Henrik M. Dahl, Michael T. Ryan, David R. Thorburn
Published in Volume 114, Issue 6
J Clin Invest. 2004; 114(6):837–845 doi:10.1172/JCI20683
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 1

Representative fusions of individual patient cell lines and of patient cell lines and a ρ0 (r0) cell line (lacking mtDNA) and a control cell line. Results are shown as complex I activity relative to the mitochondrial matrix marker enzyme CS, as percentage of the mean of fusions between control cell lines (observed range for complex I activity relative to CS activity: 164_169, n = 2 fusions). Error bars represent the observed range for all values for each cell line. N, transformed control fibroblasts; ρ0, transformed 143BTK_ρ0 osteosarcoma cell line; A, B, C, D, E, and G, complex I_deficient transformed fibroblasts from patients A_G; others, hybrids between the parental cell lines as indicated. For the parental cell lines, the mean and observed ranges for the G418-resistant and hygromycin B_resistant lines combined are shown. Number of estimations for each cell line were: N, n = 23; ρ0, A, and C, n = 8; B, n = 11; D, n = 14; E, n = 9; G, n = 7; G2, n = 1; A × B, B × ρ0, A × N, C × ρ0, D × ρ0, E × N, G × G2, G × ρ0, and G × N, n = 2; A × ρ0, n = 3; B × C, C × N, D × N, and E × ρ0, n = 4; D × E, n = 6; B × N, n = 8. (A) Affected brothers G and G2 are in the same (nuclear) complementation group. (B) Patients A and B represent 2 different (nuclear) complementation groups. (C) Patients B and C represent the same (nuclear) complementation group. (D) Patients D and E represent the same (mtDNA) complementation group.